Quick Heal Technologies Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
QUICKHEAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 6.2 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Quick Heal Technologies reported a significant decline in Q4 FY26 performance with revenue falling 25% YoY to ₹48.73 Cr and a net loss of ₹19.94 Cr. For the full year FY26, revenue declined 6.6% to ₹261.02 Cr from ₹279.53 Cr, with the company posting a net loss of ₹10.93 Cr compared to a profit of ₹5.04 Cr in FY25. EBITDA turned deeply negative at ₹29.4 Cr for FY26 versus ₹6.6 Cr loss in FY25. The consumer vertical experienced a 71.9% revenue decline in Q4 and 24.7% for the year due to industry headwinds and hardware price increases, while the enterprise vertical delivered 22.5% growth to ₹148.4 Cr. The auditors issued an unmodified opinion on the financial statements. The company also announced the appointment of Mr. Rohit Kachroo as Senior Director - IT & Digital Transformation.
The company swung from profitability to a net loss in FY26, with worsening EBITDA margins and significant revenue decline in its consumer business. The stock may face negative sentiment given the steep decline in Q4 and full-year profitability, though the enterprise segment shows resilience.